Viral Inactivation in Bioprocessing using HP Beta-Cyclodextrin

Webinar Replay: Innovative Virus Inactivation in Bioprocessing with Hydroxypropyl Beta-Cyclodextrin

Dive into the future of virus inactivation with our latest webinar replay, featuring an in-depth case study on hydroxypropyl beta-cyclodextrin (HPBCD), a multi-compendia excipient that promises to revolutionize biopharmaceutical manufacturing. Discover how HPBCD stands out as a safer, more effective, and environmentally friendly alternative to traditional virus inactivation products.

What Will You Learn?

• HPBCD as a Safer Alternative: Explore the advantages of hydroxypropyl beta-cyclodextrin over conventional detergents for viral inactivation in bioprocessing.
• Viral Clearance Efficiency: Gain insights into the superior virus inactivation capabilities of HPBCD, demonstrated through viral clearance studies with Xenotropic Murine Leukemia Virus (X-MuLV) and Herpes simplex virus (HSV-1).
• Downstream Process Compatibility: Learn how HPBCD integrates seamlessly into downstream processes, maintaining protein stability and ensuring efficient impurity removal during chromatography steps.
• Regulatory Considerations: Understand the regulatory aspects of HPBCD removal and detection in biologic processing, vital for compliance in large-scale biopharmaceutical manufacturing.

This webinar replay is essential for professionals seeking to enhance their knowledge of innovative virus inactivation methods and improve their bioprocessing efficiency. Don't miss out on the opportunity to stay ahead in the rapidly evolving field of biopharmaceuticals.